Transflo expands fleet and driver app features
TomTom unveils Trucker tool
GlaxoSmithKline prescribes commercial reboot for pharma division
In January, GlaxoSmithKline's (GSK.L) new head of pharmaceuticals Luke Miels issued a blunt challenge to his managers: find budget savings of 20 percent. Miels - a long-time protege of AstraZeneca (AZN.L) CEO Pascal Soriot, whose departure sparked a legal spat between the rival drugmakers - is a key lieutenant for Walmsley as she tries to overhaul the core pharma business. The unit has lagged rivals like Novartis (NOVN.S) and Merck & Co (MRK.N) in producing multibillion-dollar blockbusters, so Walmsley has prioritised plans to refocus both its research and marketing efforts in a drive for fewer but bigger new drugs.
4 Costly Retirement Mistakes to Avoid
These blunders could really derail your golden years.
Kenworth La Sarre relocates to bigger facility
Digital diagnostics: A trucking ‘best-kept’ secret
Google is reportedly acquiring Lytro for around $40 million
Lytro burst onto the scene in 2011 with its then-unprecedented "light field"